Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes
Chandan Sona, … , Laszlo Nagy, Matthew N. Poy
Chandan Sona, … , Laszlo Nagy, Matthew N. Poy
Published February 8, 2022
Citation Information: JCI Insight. 2022;7(6):e153136. https://doi.org/10.1172/jci.insight.153136.
View: Text | PDF
Clinical Research and Public Health Endocrinology

Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes

  • Text
  • PDF
Abstract

BACKGROUND Pathophysiology of type 1 diabetes (T1D) is illustrated by pancreatic islet infiltration of inflammatory lymphocytes, including CD8+ T cells; however, the molecular factors mediating their recruitment remain unknown. We hypothesized that single-cell RNA-sequencing (scRNA-Seq) analysis of immune cell populations isolated from islets of NOD mice captured gene expression dynamics providing critical insight into autoimmune diabetes pathogenesis.METHODS Pancreatic sections from human donors were investigated, including individuals with T1D, autoantibody-positive (aAb+) individuals, and individuals without diabetes who served as controls. IHC was performed to assess islet hormones and both novel and canonical immune cell markers that were identified from unbiased, state-of-the-art workflows after reanalyzing murine scRNA-Seq data sets.RESULTS Computational workflows identified cell adhesion molecule 1–mediated (Cadm1-mediated) homotypic binding among the most important intercellular interactions among all cell clusters, as well as Cadm1 enrichment in macrophages and DCs from pancreata of NOD mice. Immunostaining of human pancreata revealed an increased number of CADM1+glucagon+ cells adjacent to CD8+ T cells in sections from T1D and aAb+ donors compared with individuals without diabetes. Numbers of CADM1+CD68+ peri-islet myeloid cells adjacent to CD8+ T cells were also increased in pancreatic sections from both T1D and aAb+ donors compared with individuals without diabetes.CONCLUSION Increased detection of CADM1+ cells adjacent to CD8+ T cells in pancreatic sections of individuals with T1D and those who were aAb+ validated workflows and indicated CADM1-mediated intercellular contact may facilitate islet infiltration of cytotoxic T lymphocytes and serve as a potential therapeutic target for preventing T1D pathogenesis.FUNDING The Johns Hopkins All Children’s Foundation Institutional Research Grant Program, the National Natural Science Foundation of China (grant 82071326), and the Deutsche Forschungsgemeinschaft (grants 431549029–SFB1451, EXC2030–390661388, and 411422114-GRK2550).

Authors

Chandan Sona, Yu-Te Yeh, Andreas Patsalos, Laszlo Halasz, Xin Yan, Natalia L. Kononenko, Laszlo Nagy, Matthew N. Poy

×

Total citations by year

Year: 2025 2024 2023 2022 Total
Citations: 1 5 2 1 9
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (9)

Title and authors Publication Year
Partial remission of Type 1 diabetes: Do Immunometabolic Events Define the Honeymoon Period?
Collier JJ, Wasserfall CH, Brehm MA, Karlstad MD
Diabetes, obesity & metabolism 2025
Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection
Yang K, Zhang Y, Ding J, Li Z, Zhang H, Zou F
Frontiers in Endocrinology 2024
Dual role of neuroplastin in pancreatic β cells: Regulating insulin secretion and promoting islet inflammation
Kitamura RA, Hummel D, Ustione A, Piston DW, Urano F
Proceedings of the National Academy of Sciences of the United States of America 2024
Chemical mapping of the surface interactome of PIEZO1 identifies CADM1 as a modulator of channel inactivation
Koster AK, Yarishkin O, Dubin AE, Kefauver JM, Pak RA, Cravatt BF, Patapoutian A
Proceedings of the National Academy of Sciences of the United States of America 2024
Temporal maturation of Sertoli cells during the establishment of the cycle of the seminiferous epithelium
Havel SL, Griswold MD
Biology of Reproduction 2024
The Microbiota and Evolution of Obesity
Saad MJ, Santos A
Endocrine Reviews 2024
Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity
Hermans D, van Beers L, Broux B
Biology 2023
New discoveries in the field of metabolism by applying single-cell and spatial omics
Xie B, Gao D, Zhou B, Chen S, Wang L
Journal of Pharmaceutical Analysis 2023
Type 1 diabetes and engineering enhanced islet transplantation
Jeyagaran A, Lu CE, Zbinden A, Birkenfeld AL, Brucker SY, Layland SL
Advanced Drug Delivery Reviews 2022

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts